Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-22-102340
Filing Date
2022-09-22
Accepted
2022-09-22 16:15:39
Documents
2
Group Members
HEIDI S. SHIPPELL-HEILAND 2008 IRREVOCABLE TRUSTMICHAEL TOROK

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2226448d1_sc13da.htm SC 13D/A 60739
2 EXHIBIT 99.5 tm2226448d1_ex99-5.htm EX-99.5 6916
  Complete submission text file 0001104659-22-102340.txt   69270
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Subject) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82442 | Film No.: 221259396
SIC: 2834 Pharmaceutical Preparations

Mailing Address 68 MAZZEO DRIVE RANDOLPH MA 02368
Business Address 68 MAZZEO DRIVE RANDOLPH MA 02368 617-680-6709
JEC II Associates, LLC (Filed by) CIK: 0001477326 (see all company filings)

EIN.: 262258828 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A